These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 27543509

  • 1. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I, Minaidou E, Leontara V, Mantas D, Sotiropoulos GC, Tsipras H, Zografos GN, Margaris I, Kouraklis G.
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [Abstract] [Full Text] [Related]

  • 2. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I, Minaidou E, Mantas D, Sotiropoulos GC, Leontara V, Tsipras H, Zografos GN, Margaris I, Kouraklis G.
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [Abstract] [Full Text] [Related]

  • 3. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF, Shen DH, Wang HL, Ma YT, Yuan F, Liu J, Chen L, Song QJ, Zhang YY.
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb 08; 48(2):92-97. PubMed ID: 30695858
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM.
    Am J Surg Pathol; 2005 Mar 08; 29(3):359-67. PubMed ID: 15725805
    [Abstract] [Full Text] [Related]

  • 5. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N, Prabha K, Singh RK, Baitha DK, Krishnani N.
    Hum Pathol; 2013 Oct 08; 44(10):2213-9. PubMed ID: 23834763
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y, Reid MD, Balci S, Quigley B, Muraki T, Memis B, Xia J, Hacihasanoglu E, Bedolla G, Pehlivanoglu B, Kim GE, Tajiri T, Ohike N, Aneja R, Krasinskas AM, Adsay V.
    Am J Surg Pathol; 2017 Jul 08; 41(7):865-876. PubMed ID: 28505002
    [Abstract] [Full Text] [Related]

  • 7. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB, Patzina RA, Penteado S, Montagnini AL, da Cunha JE, Machado MC, Jukemura J.
    J Gastrointest Surg; 2010 Apr 08; 14(4):719-28. PubMed ID: 20107918
    [Abstract] [Full Text] [Related]

  • 8. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC, Shia J, Tang LH, Katabi N, Klimstra DS.
    Am J Surg Pathol; 2014 Oct 08; 38(10):1371-9. PubMed ID: 24832159
    [Abstract] [Full Text] [Related]

  • 9. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
    Zhou H, Schaefer N, Wolff M, Fischer HP.
    Am J Surg Pathol; 2004 Jul 08; 28(7):875-82. PubMed ID: 15223956
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
    da Silveira Santos JPL, Machado CJ, Junior EP, Rodrigues JBSR, Vidigal PT, Resende V.
    J Gastrointest Surg; 2018 Jul 08; 22(7):1171-1178. PubMed ID: 29736668
    [Abstract] [Full Text] [Related]

  • 11. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
    Kawabata Y, Tanaka T, Nishisaka T, Inao T, Nishi T, Yano S.
    Diagn Pathol; 2010 Nov 25; 5():75. PubMed ID: 21106111
    [Abstract] [Full Text] [Related]

  • 12. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
    Zhao XQ, Dong JH, Zhang WZ, Liu Z.
    Diagn Pathol; 2011 Oct 13; 6():98. PubMed ID: 21992455
    [Abstract] [Full Text] [Related]

  • 13. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
    Morini S, Perrone G, Borzomati D, Vincenzi B, Rabitti C, Righi D, Castri F, Manazza AD, Santini D, Tonini G, Coppola R, Onetti Muda A.
    Pancreas; 2013 Jan 13; 42(1):60-6. PubMed ID: 22889982
    [Abstract] [Full Text] [Related]

  • 14. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
    Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV.
    J Clin Oncol; 2013 Apr 01; 31(10):1348-56. PubMed ID: 23439753
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
    Leo JM, Kalloger SE, Peixoto RD, Gale NS, Webber DL, Owen DA, Renouf D, Schaeffer DF.
    J Clin Pathol; 2016 May 01; 69(5):431-9. PubMed ID: 26500334
    [Abstract] [Full Text] [Related]

  • 16. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
    Xue Y, Vanoli A, Balci S, Reid MM, Saka B, Bagci P, Memis B, Choi H, Ohike N, Tajiri T, Muraki T, Quigley B, El-Rayes BF, Shaib W, Kooby D, Sarmiento J, Maithel SK, Knight JH, Goodman M, Krasinskas AM, Adsay V.
    Mod Pathol; 2017 Feb 01; 30(2):255-266. PubMed ID: 27739441
    [Abstract] [Full Text] [Related]

  • 17. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
    Yun SP, Seo HI.
    BMC Gastroenterol; 2015 Nov 24; 15():165. PubMed ID: 26603157
    [Abstract] [Full Text] [Related]

  • 18. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
    Schueneman A, Goggins M, Ensor J, Saka B, Neishaboori N, Lee S, Maitra A, Varadhachary G, Rezaee N, Wolfgang C, Adsay V, Wang H, Overman MJ.
    Br J Cancer; 2015 Jun 30; 113(1):64-8. PubMed ID: 25989273
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
    Jun SY, Eom DW, Park H, Bae YK, Jang KT, Yu E, Hong SM.
    Mod Pathol; 2014 Oct 30; 27(10):1364-74. PubMed ID: 24603585
    [Abstract] [Full Text] [Related]

  • 20. Expression of MUC1 and MUC2 in ampullary cancer.
    Moriya T, Kimura W, Hirai I, Takasu N, Mizutani M.
    Int J Surg Pathol; 2011 Aug 30; 19(4):441-7. PubMed ID: 21700631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.